Furthermore, as the number of HCC patients who are in early stages of the disease, bear small tumor nodules (<3 cm), or display normal serum level of AFP is increasing, finding new prognosis prediction biomarker for these patients represents a major challenge in the clinic. Here, AFP is linked to neoplasm.